---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-009017"
form_type: "8-K"
ticker: "CELU"
cik: "0001752828"
company_name: "Celularity Inc"
filed_at: "2026-03-05T23:59:59+00:00"
generated_at: "2026-05-15T19:46:36.250103+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Celularity CFO Joseph DosSantos departs; John Sprague named acting CFO

## Summary
- Joseph DosSantos left as SVP Finance and Acting CFO on Feb 27, 2026 for personal reasons.
- John Sprague appointed Acting CFO effective same date.
- No additional details on compensation or transition timeline provided.

## SEC filing metadata
- accession: 0001493152-26-009017
- form_type: 8-K
- ticker: CELU
- cik: 0001752828
- company_name: Celularity Inc
- filed_at: 2026-03-05T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1752828/000149315226009017/0001493152-26-009017-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1752828/000149315226009017/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-009017
- JSON: https://secwatch.observer/filing/0001493152-26-009017.json
- Plain text: https://secwatch.observer/filing/0001493152-26-009017.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.